U.S. Auto Stock News

What Zenas BioPharma’s recent performance tells you Zenas BioPharma (ZBIO) has been on many watchlists after a sharp move in its share price over the past 3 months, even as shorter term returns over the past week and month have been negative. For context, the stock closed at US$34.50, with a 1 day return of about 5% decline, a 7 day return of roughly 11.7% decline, and a month return of about 12.4% decline, while the past 3 months show a gain above 65%. If you are looking at this recent...

In recent months, Joby Aviation has expanded its air-taxi push by partnering with Metropolis Technologies to develop up to 25 vertiports across the U.S., progressing flight testing with Toyota in Japan and advancing plans for commercial eVTOL operations in the Middle East and United States. Amid ongoing losses and uncertain certification timing, Joby’s decision to double manufacturing capacity and invest in infrastructure signals a commitment to scaling its network ahead of widespread...

The Trump administration’s decision to delay planned tariff hikes on furniture imports has eased some pressure on RH (RH), which had been dealing with higher costs and supply chain disruptions. See our latest analysis for RH. That relief has coincided with a sharp 20.09% 1 month share price return to US$193.41 and a 7.96% 1 day jump. However, the 1 year total shareholder return of 53.39% decline and 5 year total shareholder return of 60.40% decline show that longer term momentum has been...

Why Welltower is on investors’ radar today Without a single headline event setting the tone, interest in Welltower (WELL) is being driven by its role in seniors and wellness housing and how its recent share performance compares with its longer term track record. See our latest analysis for Welltower. The share price is at $186.94 after a recent 8.5% 1 month share price return decline. However, a 90 day share price return of 8.06% and a 1 year total shareholder return of 53.34% show that...

Recently, BofA Securities downgraded Omnicom Group to an “Underperform” rating, citing concerns about organic growth and the earnings impact of planned asset disposals. At the same time, Omnicom has raised its dividend and continued integrating capabilities like TPN into Flywheel, underscoring its focus on retail and commerce growth alongside larger platform and acquisition plans. Next, we’ll examine how BofA’s downgrade on organic growth concerns interacts with Omnicom’s merger-driven...

Mercury Systems (MRCY) is back in focus after its latest quarter came in ahead of analysts’ expectations, with revenue up 10.2% year on year and additional growth in backlog, adjusted EBITDA, and free cash flow. See our latest analysis for Mercury Systems. The strong quarterly beat and improved cash generation have been followed by a 4.14% 1 day share price return and a 7.72% 30 day share price return, even though the 90 day share price return is an 8.91% decline and the 5 year total...

Recent trading in MDU Resources Group (MDU) has drawn attention after the stock’s 1 day move of 1.79%, alongside a one-month return of 3.17% and a three-month total return of 9.12%. See our latest analysis for MDU Resources Group. Zooming out, the recent 3 month share price return of 9.12% sits alongside a 1 year total shareholder return of 14.34%. This hints that momentum has been building rather than fading around the current US$19.87 level. If MDU Resources Group has caught your eye, it...

Bausch Health Companies (NYSE:BHC) recently completed a refinancing that exchanges existing 2028 senior secured notes for US$1.6b of new 10.00% Senior Secured Notes due 2032. This transaction reshapes its long term debt profile for investors. See our latest analysis for Bausch Health Companies. The refinancing news comes as the share price trades at US$7.21, with a 90 day share price return of 12.83% contrasting with a 1 year total shareholder return decline of 7.56%. This suggests recent...

Jefferies Financial Group stock snapshot Jefferies Financial Group (JEF) shares recently closed at $63.46, and the stock has logged mixed short term performance, including a 2.4% gain over the past day and 1.2% over the past week. See our latest analysis for Jefferies Financial Group. The recent 7.3% 1 month share price return sits against a flat year to date move and a 19.8% decline in 1 year total shareholder return. At the same time, the 5 year total shareholder return of 187.97% points to...

Zevra Therapeutics (ZVRA) drew fresh investor attention after announcing an exclusive expanded access distribution agreement with Uniphar, giving Niemann Pick Disease Type C patients reimbursed access to MIPLYFFA in select territories outside Europe. See our latest analysis for Zevra Therapeutics. The Uniphar agreement arrives during a softer patch for the stock, with a 90 day share price return of an 18.16% decline and a 1 year total shareholder return of a 1.18% decline. However, the 3 year...

Moelis (MC) is back in focus after its latest quarterly earnings, where revenue grew 33.9% year on year but came in 3.2% below expectations, while EPS topped forecasts and EBITDA missed. See our latest analysis for Moelis. The mixed earnings reaction sits alongside a 6.6% 90 day share price return and a 3.7% 30 day share price return. At the same time, the 3 year total shareholder return of 90.95% contrasts with a slightly negative 1 year total shareholder return, suggesting momentum has...

Crown Castle (CCI) owns around 40,000 cell towers and 90,000 route miles of fiber across major U.S. markets, so its recent share moves have investors revisiting how this infrastructure-focused REIT is currently valued. See our latest analysis for Crown Castle. At a share price of $88.70, Crown Castle’s recent 90 day share price return of a 6.77% decline sits against a 1 year total shareholder return of 5.34%, suggesting short term momentum has faded while longer term returns remain mixed. If...

In the past five years, Impinj has reported annual revenue growth of 20.2%, alongside earnings per share increasing at a much faster 49.4% rate and strengthened free cash flow margins. This combination of faster earnings growth relative to revenue and improved cash generation suggests the business has been converting new sales into profit more efficiently over this period. Building on this efficiency-driven earnings expansion, we’ll now examine how the improved free cash flow profile...

Why Invitation Homes is on investors’ radar today Invitation Homes (INVH) is back in focus as investors reassess single family rental stocks, with the share price at US$27.72 and recent returns mixed over the past year and past 3 months. See our latest analysis for Invitation Homes. The recent 1 month share price return of 2.14% contrasts with a 1 year total shareholder return decline of 7.65%. This suggests interest has been uneven as investors reassess risk and income prospects in single...

Chewy (CHWY) has drawn investor attention after recent trading left the shares with a return of about 0% over the past month, while the past 3 months show roughly an 11% decline. See our latest analysis for Chewy. Chewy’s 1-day share price return of 1.33% and 7-day share price return of 0.69% sit against a 90-day share price decline of 11%. The 1-year total shareholder return of 9.66% and 5-year total shareholder return of 65.53% indicate that longer term momentum has been fading. If Chewy’s...

On January 5, 2026, QXO, Inc. entered into an agreement to issue up to 114,500 Series C Convertible Perpetual Preferred Shares at US$10,000 each, raising up to US$1.15 billion from investors including Apollo-managed AP Quince Holdings (US$845,000,000) and Franklin Advisers (US$300,000,000), with closing targeted for July 15, 2026. This preferred stock, carrying a 4.75% annual dividend and conversion into common shares at an initial US$23.25 price, is earmarked to fund acquisitions in...

In late December 2025, Morgan Stanley and Bank of America Securities reaffirmed their views on Coherent while emphasizing stronger demand for the company’s optical transceivers and components tied to AI-related infrastructure and ongoing supply constraints. This renewed focus on Coherent’s role in supplying critical optics for AI datacenters underscores how capacity, not just technology, is becoming a key competitive differentiator. We’ll now examine how analysts’ emphasis on AI-driven...

A fresh analyst report on PVH Corp (PVH) has raised concerns, pointing to weak constant currency growth, a low free cash flow margin, and declining returns on capital as signs of ongoing fundamental pressure. See our latest analysis for PVH. PVH shares closed at $67.82, and the recent analyst caution comes after a 30 day share price return decline of 13.59% and a 1 year total shareholder return decline of 36.96%, indicating fading momentum despite earlier sector strength. If PVH’s recent...

Recent commentary around Entegris (ENTG) centers on its role in supplying materials and purity solutions for advanced semiconductor production, as investors watch for order stabilization tied to AI infrastructure projects and related chip manufacturing investments. See our latest analysis for Entegris. The recent commentary around AI related ordering has arrived alongside a 1 day share price return of 6.3% to US$89.56, while the 1 year total shareholder return of a 12.24% decline and 3 year...

Why Byrna Technologies is on investors’ radar Byrna Technologies (BYRN) has drawn fresh attention after a period of mixed share performance, with gains over the past week contrasting with weaker moves over the past month and past 3 months. See our latest analysis for Byrna Technologies. At a share price of $16.72, Byrna Technologies has seen a 4.04% 7 day share price return. However, the 30 and 90 day share price returns of 15% and 26.05% suggest recent momentum has been fading. This comes...

U.S. Physical Therapy, Inc. recently acquired a 50% interest in a physical therapy management services company that oversees eight outpatient clinics generating about US$8,000,000 in annual revenue from roughly 66,000 patient visits. This partnership structure, with the original owners retaining the remaining 50%, allows U.S. Physical Therapy to broaden its clinic footprint while sharing operational control and financial risk. We’ll now examine how acquiring a 50% stake in an eight-clinic...

General Mills (GIS) has been drawing investor attention after a stretch of weaker share performance, including a 22.26% decline over the past year, prompting fresh questions about how its current valuation compares. See our latest analysis for General Mills. At a share price of US$45.72, General Mills has seen pressure build over the past year, with a 90 day share price return of 10.23% and a 1 year total shareholder return of 22.26%. This suggests momentum has been fading rather than...

T-Mobile US (TMUS) stock has recently been on the radar for investors after a period of weaker share performance, including a 4.8% decline over the past month and 12.3% over the past 3 months. See our latest analysis for T-Mobile US. Zooming out, T-Mobile US’s recent 1 day and 7 day share price declines come after a weaker 3 month patch, while its 3 year and 5 year total shareholder returns remain positive. This suggests momentum has softened recently even as longer term holders are still...

Why Booking Holdings Is On Investors’ Radar Today Booking Holdings (BKNG) is drawing attention after recent share price moves, with the stock showing mixed short term returns and a modest gain over the past month. Investors are weighing these moves against the company’s current fundamentals. See our latest analysis for Booking Holdings. At a share price of $5,323.20, Booking Holdings has seen short term share price softness, with a 1 day return decline of 0.60% and a 7 day return decline of...